Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters

Podcast

“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Amy E. Krambeck, MD. She discusses the recent Journal of Endourology study, "Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial," for which she served as senior author. Krambeck is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.

Related Videos
Katherine Chan, MD, MPH, answers a question during a Zoom virtual interview
John Michael DiBianco, MD, answers a question during a Zoom video interview
Human kidney cross section on science background | Image Credit: © Crystal light - stock.adobe.com
Katherine Chan, MD, MPH, answers a question during a Zoom video interview
Human kidney cross section on scientific background | Image Credit: © Crystal light - stock.adobe.com
Katherine Chan, MD, MPH, gives an answer during a Zoom video interview
Image of kidneys | Image Credit: © peterschreiber.media - stock.adobe.com
Jenny Guo, MD, answers a question during a Zoom video interview
Human kidney cross section on scientific background | © Crystal light - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.